Harmony Biosciences Holdings (HRMY) — Free Cash Flow Generation Index
Harmony Biosciences Holdings (HRMY) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $27.76 Million represents 1% of operating cash flow ($27.76 Million). Read Harmony Biosciences Holdings debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Harmony Biosciences Holdings Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for Harmony Biosciences Holdings across 5 annual periods. Explore Harmony Biosciences Holdings capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Harmony Biosciences Holdings (2021–2025)
Year-by-year Free Cash Flow Generation Index for Harmony Biosciences Holdings. For the full company profile including market capitalisation, see HRMY market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $347.89 Million | $348.20 Million | $310.00K | ▲ +0.4% |
| 2024 | 0.99x | $218.67 Million | $219.82 Million | $1.15 Million | ▼ -0.4% |
| 2023 | 1.00x | $219.07 Million | $219.39 Million | $312.00K | ▼ 0.0% |
| 2022 | 1.00x | $144.29 Million | $144.47 Million | $172.00K | ▲ +0.2% |
| 2021 | 1.00x | $98.26 Million | $98.56 Million | $298.00K | — |